Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping
<p>Abstract</p> <p>Background</p> <p>We have previously used the rat 4 day Complete Freund's Adjuvant (CFA) model to screen compounds with potential to reduce osteoarthritic pain. The aim of this study was to identify genes altered in this model of osteoarthritic p...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2010-09-01
|
| Series: | Molecular Pain |
| Online Access: | http://www.molecularpain.com/content/6/1/56 |
| _version_ | 1818206774484795392 |
|---|---|
| author | Chang Meiping Smith Sarah Thorpe Andrew Barratt Michael J Karim Farzana |
| author_facet | Chang Meiping Smith Sarah Thorpe Andrew Barratt Michael J Karim Farzana |
| author_sort | Chang Meiping |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>We have previously used the rat 4 day Complete Freund's Adjuvant (CFA) model to screen compounds with potential to reduce osteoarthritic pain. The aim of this study was to identify genes altered in this model of osteoarthritic pain and use this information to infer analgesic potential of compounds based on their own gene expression profiles using the Connectivity Map approach.</p> <p>Results</p> <p>Using microarrays, we identified differentially expressed genes in L4 and L5 dorsal root ganglia (DRG) from rats that had received intraplantar CFA for 4 days compared to matched, untreated control animals. Analysis of these data indicated that the two groups were distinguishable by differences in genes important in immune responses, nerve growth and regeneration. This list of differentially expressed genes defined a "CFA signature". We used the Connectivity Map approach to identify pharmacologic agents in the Broad Institute Build02 database that had gene expression signatures that were inversely related ('negatively connected') with our CFA signature. To test the predictive nature of the Connectivity Map methodology, we tested phenoxybenzamine (an alpha adrenergic receptor antagonist) - one of the most negatively connected compounds identified in this database - for analgesic activity in the CFA model. Our results indicate that at 10 mg/kg, phenoxybenzamine demonstrated analgesia comparable to that of Naproxen in this model.</p> <p>Conclusion</p> <p>Evaluation of phenoxybenzamine-induced analgesia in the current study lends support to the utility of the Connectivity Map approach for identifying compounds with analgesic properties in the CFA model.</p> |
| first_indexed | 2024-12-12T04:18:22Z |
| format | Article |
| id | doaj.art-827ff00faa58430b9cdeb2ec8de5ac7e |
| institution | Directory Open Access Journal |
| issn | 1744-8069 |
| language | English |
| last_indexed | 2024-12-12T04:18:22Z |
| publishDate | 2010-09-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Molecular Pain |
| spelling | doaj.art-827ff00faa58430b9cdeb2ec8de5ac7e2022-12-22T00:38:23ZengSAGE PublishingMolecular Pain1744-80692010-09-01615610.1186/1744-8069-6-56Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mappingChang MeipingSmith SarahThorpe AndrewBarratt Michael JKarim Farzana<p>Abstract</p> <p>Background</p> <p>We have previously used the rat 4 day Complete Freund's Adjuvant (CFA) model to screen compounds with potential to reduce osteoarthritic pain. The aim of this study was to identify genes altered in this model of osteoarthritic pain and use this information to infer analgesic potential of compounds based on their own gene expression profiles using the Connectivity Map approach.</p> <p>Results</p> <p>Using microarrays, we identified differentially expressed genes in L4 and L5 dorsal root ganglia (DRG) from rats that had received intraplantar CFA for 4 days compared to matched, untreated control animals. Analysis of these data indicated that the two groups were distinguishable by differences in genes important in immune responses, nerve growth and regeneration. This list of differentially expressed genes defined a "CFA signature". We used the Connectivity Map approach to identify pharmacologic agents in the Broad Institute Build02 database that had gene expression signatures that were inversely related ('negatively connected') with our CFA signature. To test the predictive nature of the Connectivity Map methodology, we tested phenoxybenzamine (an alpha adrenergic receptor antagonist) - one of the most negatively connected compounds identified in this database - for analgesic activity in the CFA model. Our results indicate that at 10 mg/kg, phenoxybenzamine demonstrated analgesia comparable to that of Naproxen in this model.</p> <p>Conclusion</p> <p>Evaluation of phenoxybenzamine-induced analgesia in the current study lends support to the utility of the Connectivity Map approach for identifying compounds with analgesic properties in the CFA model.</p>http://www.molecularpain.com/content/6/1/56 |
| spellingShingle | Chang Meiping Smith Sarah Thorpe Andrew Barratt Michael J Karim Farzana Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping Molecular Pain |
| title | Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping |
| title_full | Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping |
| title_fullStr | Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping |
| title_full_unstemmed | Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping |
| title_short | Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping |
| title_sort | evaluation of phenoxybenzamine in the cfa model of pain following gene expression studies and connectivity mapping |
| url | http://www.molecularpain.com/content/6/1/56 |
| work_keys_str_mv | AT changmeiping evaluationofphenoxybenzamineinthecfamodelofpainfollowinggeneexpressionstudiesandconnectivitymapping AT smithsarah evaluationofphenoxybenzamineinthecfamodelofpainfollowinggeneexpressionstudiesandconnectivitymapping AT thorpeandrew evaluationofphenoxybenzamineinthecfamodelofpainfollowinggeneexpressionstudiesandconnectivitymapping AT barrattmichaelj evaluationofphenoxybenzamineinthecfamodelofpainfollowinggeneexpressionstudiesandconnectivitymapping AT karimfarzana evaluationofphenoxybenzamineinthecfamodelofpainfollowinggeneexpressionstudiesandconnectivitymapping |